Brosius Mark - Feb 29, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Stephanie Lim-Ignacio For: Brosius, Mark
Stock symbol
ISRG
Transactions as of
Feb 29, 2024
Transactions value $
-$361,462
Form type
4
Date filed
2/29/2024, 07:38 PM
Previous filing
Feb 27, 2024
Next filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $0 +966 +85.49% $0.00 2.1K Feb 29, 2024 Direct F1
transaction ISRG Common Stock Tax liability -$189K -490 -23.38% $386.59 1.61K Feb 29, 2024 Direct F1
transaction ISRG Common Stock Options Exercise $0 +877 +54.61% $0.00 2.48K Feb 29, 2024 Direct F1
transaction ISRG Common Stock Tax liability -$172K -445 -17.92% $386.59 2.04K Feb 29, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Restricted Stock Units - 2-28-2020 Options Exercise $0 -966 -100% $0.00* 0 Feb 29, 2024 Common Stock 966 $0.00 Direct F2
transaction ISRG Restricted Stock Units - 2-28-2022 Options Exercise $0 -877 -33.33% $0.00 1.75K Feb 29, 2024 Common Stock 877 $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F2 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.